Protalix BioTherapeutics Balance Sheet (2010-2026) | PLX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	33.88M	10.64M	38.98M	16.89M	12.49M	10.72M	17.11M	33.04M	48.18M	20.41M	23.63M	27.21M	23.40M	27.41M		19.46M	17.89M	13.65M	0.70M	0.71M
Short-term Investments (Quarter)	43.06M	38.02M		16.03M	16.08M	10.09M	5.07M			20.57M	20.93M	21.28M	21.63M		15.07M	15.29M	15.50M	15.72M	15.59M	10.08M
Cash & Current Investments (Quarter)	76.94M	48.66M	38.98M	32.92M	28.57M	20.81M	22.18M	33.04M	48.18M	40.98M	44.56M	48.49M	45.03M	27.41M	15.07M	34.74M	33.40M	29.37M	16.30M	10.79M
Receivables - Net (Quarter)	2.33M	5.56M	3.44M	5.91M	2.02M	8.65M	4.59M	1.30M	4.05M	8.94M	5.27M	3.76M	10.13M	2.19M	2.91M	4.67M	9.44M	14.43M	8.84M	2.94M
Receivables - Other (Quarter)
Receivables (Quarter)	2.33M	5.56M	3.44M	5.91M	2.02M	8.65M	4.59M	1.30M	4.05M	8.94M	5.27M	3.76M	10.13M	2.19M	2.91M	4.67M	9.44M	14.43M	8.84M	2.94M
Raw Materials (Quarter)	3.05M	3.17M	3.17M	3.07M	3.30M	3.66M	3.51M	4.31M	4.35M	4.20M	4.18M	4.02M	4.30M	4.24M	4.55M	4.48M	4.36M	4.98M	5.98M	6.01M
Work In Process (Quarter)	3.06M	3.51M	3.26M	3.37M	3.30M	2.62M	2.68M	1.53M	3.32M	9.12M	9.05M	9.17M	10.87M	12.25M	11.24M	8.00M	8.14M	5.36M	9.38M	9.08M
Finished Goods (Quarter)	7.53M	8.05M	11.53M	10.16M	9.91M	8.28M	10.62M	14.46M	11.96M	8.27M	5.81M	9.15M	5.54M	0.71M	5.45M	7.02M	8.63M	10.92M	10.37M	15.38M
Inventory (Quarter)	13.64M	14.73M	17.95M	16.59M	16.51M	14.56M	16.80M	20.30M	19.64M	21.58M	19.05M	22.35M	20.72M	17.20M	21.24M	19.51M	21.13M	21.25M	25.73M	30.47M
Prepaid Assets (Quarter)	3.01M	2.27M	0.91M	1.12M	2.60M	1.74M	1.31M	0.76M	1.71M	1.12M	0.44M	0.81M	1.49M	1.05M	0.50M	1.59M	1.51M	1.45M	1.13M	1.15M
Current Assets (Quarter)	95.92M	71.22M	61.67M	56.54M	49.70M	45.76M	44.88M	55.40M	73.58M	72.62M	69.93M	75.40M	77.37M	47.85M	60.08M	60.51M	65.48M	66.50M	66.67M	86.36M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	4.99M	5.07M	4.96M	4.89M	4.77M	4.68M	4.55M	4.70M	4.64M	4.68M	4.97M	4.78M	4.61M	4.65M	4.59M	4.72M	4.75M	4.72M	4.88M	5.15M
Long-Term Investments (Quarter)
Long-Term Deferred Tax (Quarter)									3.13M	3.09M	3.09M	3.23M	3.30M	2.86M	2.86M	2.97M	2.74M	2.68M	2.52M	2.44M
Other Non-Current Assets (Quarter)	1.88M	1.95M	2.08M	2.05M	1.40M	1.42M	1.27M	1.25M	1.27M	1.26M	0.53M	0.53M	0.54M	0.56M	0.46M	0.46M	0.52M	0.55M	0.58M	0.59M
Non-Current Assets (Quarter)	12.28M	12.26M	12.00M	11.85M	10.94M	10.95M	10.91M	11.16M	14.84M	14.95M	14.50M	14.42M	14.17M	13.71M	13.34M	13.38M	13.00M	15.76M	15.67M	15.98M
Assets (Quarter)	108.20M	83.48M	73.67M	68.39M	60.64M	56.71M	55.79M	66.56M	88.42M	87.57M	84.43M	89.83M	91.54M	61.56M	73.42M	73.89M	78.49M	82.26M	82.35M	102.34M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	14.42M	14.69M	16.43M	14.41M	12.66M	12.87M	5.86M	13.47M	18.55M	18.74M	4.32M	18.77M	4.06M	19.58M	4.53M	4.12M	6.69M	5.38M	5.26M	4.29M
Notes Payables (Quarter)
Payables (Quarter)	14.42M	14.69M	16.43M	14.41M	12.66M	12.87M	5.86M	13.47M	18.55M	18.74M	4.32M	18.77M	4.06M	19.58M	4.53M	4.12M	6.69M	5.38M	5.26M	4.29M
Accumulated Expenses (Quarter)											9.01M				1.81M	1.35M	0.76M	8.13M	0.80M	3.71M
Short term Debt (Quarter)	56.35M	3.24M								20.19M	20.25M	20.42M	20.42M
Current Leases (Quarter)	1.24M	1.24M	1.21M	1.24M	1.08M	1.00M	1.12M	1.15M	1.26M	1.31M	1.41M	1.45M	1.45M	1.51M	1.50M	1.43M	1.47M	1.40M	1.38M	1.43M
Current Taxes (Quarter)											2.88M				3.48M	3.48M	3.74M	2.38M	2.95M	3.20M
Current Deferred Revenue (Quarter)	18.11M	15.16M	8.55M	11.80M	10.22M	14.79M	13.18M	11.79M				11.04M	12.70M			2.00M
Total Current Liabilities (Quarter)	96.25M	42.76M	33.18M	35.33M	30.96M	34.30M	32.43M	31.52M	23.11M	43.36M	45.53M	54.83M	57.97M	24.22M	25.62M	24.32M	24.09M	21.95M	26.52M	27.39M
Non-Current Liabilities
Non-Current Debt (Quarter)
Convertible Debt (Quarter)		27.82M	27.89M	27.96M	28.03M	28.11M	28.19M	28.27M	20.13M		20.42M
Non-Current Deffered Revenue (Quarter)	1.27M	5.89M	11.79M	5.89M	5.89M
Pension (Quarter)	2.30M	2.35M	2.47M	2.50M	1.75M	1.78M	1.64M	1.62M	1.60M	1.46M	0.71M	0.71M	0.70M	0.73M	0.56M	0.55M	0.61M	0.63M	0.66M	0.67M
Liabilities from Discontinued Operations (Quarter)
Operating Leases (Quarter)	4.51M	4.44M	4.38M	4.19M	3.89M	4.03M	4.17M	4.15M	4.58M	4.50M	4.62M	4.50M	4.28M	4.18M	4.03M	3.81M	3.88M	6.78M	6.94M	7.05M
Other Non-Current Liabilities (Quarter)	0.04M
Total Non-Current Liabilities (Quarter)	8.12M	40.51M	46.52M	40.55M	39.57M	33.92M	34.00M	34.04M	26.31M	5.96M	5.33M	5.21M	4.99M	4.91M	4.58M	4.36M	4.49M	7.41M	7.60M	7.72M
Total Liabilities (Quarter)	104.36M	83.27M	79.70M	75.88M	70.53M	68.22M	66.43M	65.55M	49.42M	49.32M	50.87M	60.04M	62.96M	29.13M	30.21M	28.68M	28.58M	29.36M	34.12M	35.11M
Shareholder's Equity
Total Debt (Quarter)	56.35M	3.24M								20.19M	20.25M	20.42M	20.42M
Common Equity (Quarter)	3.84M	0.21M	-6.04M	-7.49M	-9.89M	-11.51M	-10.64M	1.01M	39.00M	38.25M	33.57M	29.79M	28.58M	32.44M	43.21M	45.21M	49.90M	52.91M	48.23M	67.23M
Shareholder's Equity (Quarter)	3.84M	0.21M	-6.04M	-7.49M	-9.89M	-11.51M	-10.64M	1.01M	39.00M	38.25M	33.57M	29.79M	28.58M	32.44M	43.21M	45.21M	49.90M	52.91M	48.23M	67.23M
Liabilities and Shareholders Equity (Quarter)	108.20M	83.48M	73.67M	68.39M	60.64M	56.71M	55.79M	66.56M	88.42M	87.57M	84.43M	89.83M	91.54M	61.56M	73.42M	73.89M	78.49M	82.26M	82.35M	102.34M
Retained Earnings (Quarter)			-374.93M				-389.86M				-381.55M				-378.39M				-385.00M
Treasury Shares (Quarter)			0.46M				0.29M				1.17M				0.86M				0.74M

Research Tools

Developers

Protalix BioTherapeutics Balance Sheet (2010-2026) | PLX

Research Tools

Developers

Protalix BioTherapeutics Balance Sheet (2010-2026) | PLX

Create an account

Sign In

Reset Password